Abbott Laboratories (NYSE: ABT) is -0.08% lower on its value in year-to-date trading and has touched a low of $99.71 and a high of $121.64 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ABT stock was last observed hovering at around $113.19 in the last trading session, with the day’s loss setting it -0.17%.
Currently trading at $113.02, the stock is -0.40% and -1.95% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.94 million and changing -0.15% at the moment leaves the stock 2.21% off its SMA200. ABT registered -0.42% loss for a year compared to 6-month gain of 9.77%. The firm has a 50-day simple moving average (SMA 50) of $115.2976 and a 200-day simple moving average (SMA200) of $110.5799.
The stock witnessed a -0.98% loss in the last 1 month and extending the period to 3 months gives it a -2.67%, and is -0.02% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.52% over the week and 1.49% over the month.
Abbott Laboratories (ABT) has around 114000 employees, a market worth around $196.03B and $41.22B in sales. Current P/E ratio is 34.37 and Fwd P/E is 21.92. Profit margin for the company is 13.94%. Distance from 52-week low is 13.35% and -7.09% from its 52-week high. The company has generated returns on investments over the last 12 months (10.92%).
with sales reaching $11.03B over the same period.The EPS is expected to grow by 5.29% this year, but quarterly earnings will post 4.69% year-over-year. Quarterly sales are estimated to grow 7.72% in year-over-year returns.
Abbott Laboratories (ABT) Top Institutional Holders
3579.0 institutions hold shares in Abbott Laboratories (ABT), with institutional investors hold 77.98% of the company’s shares. The shares outstanding are 1.73B, and float is at 1.72B with Short Float at 0.83%. Institutions hold 77.57% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 166.35 million shares valued at $17.29 billion. The investor’s holdings represent 9.5932% of the ABT Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 131.13 million shares valued at $13.63 billion to account for 7.5619 of the shares outstanding. The other top investors are STATE STREET CORP which holds 74.4 million shares representing 4.2903% and valued at over $7.73 billion, while CAPITAL INTERNATIONAL INVESTORS holds 4.1405 of the shares totaling 71.8 million with a market value of $7.46 billion.
Abbott Laboratories (ABT) Insider Activity
#####
Abbott Laboratories disclosed in a document filed with the SEC on Oct 21 ’24 that ALLEN HUBERT L (EXECUTIVE VICE PRESIDENT) sold a total of 157,421 shares of the company’s common stock. The trade occurred on Oct 21 ’24 and was made at $117.04 per share for $18.42 million. Following the transaction, the insider now directly holds 0.18 million shares of the ABT stock.
Still, SEC filings show that on Oct 21 ’24, ALLEN HUBERT L (Officer) Proposed Sale 157,421 shares at an average price of $118.89 for $18.72 million. The insider now directly holds shares of Abbott Laboratories (ABT).
